Successful Results of Pamidronate Treatment in Children With Osteogenesis Imperfecta With Emphasis on the Interpretation of Bone Mineral Density for Local Standards-Reference-Cited by-同舟云学术

Successful Results of Pamidronate Treatment in Children With Osteogenesis Imperfecta With Emphasis on the Interpretation of Bone Mineral Density for Local Standards

Published:2008-06 Issue:4 Volume:28 Page:483-487
ISSN:0271-6798
Container-title:Journal of Pediatric Orthopaedics
language:en
Short-container-title:

Author:

Poyrazoglu Sukran,Gunoz Hulya,Darendeliler Feyza,Bas Firdevs,Tutunculer Filiz,Eryilmaz Sema Kabatas,Bundak Ruveyde,Saka Nurcin

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Orthopedics and Sports Medicine,General Medicine,Pediatrics, Perinatology, and Child Health

Reference36 articles.

1. Genetic heterogeneity in osteogenesis imperfecta.;Sillence;J Med Genet,1979

2. Bone resorption assessed by immunoassay of urinary cross-linked collagen peptides in patients with osteogenesis imperfecta.;Brenner;J Bone Miner Res,1994

3. Long-term effect of bisphosphonates on the growing skeleton: studies of young patients with severe osteoporosis.;Brumsen;Medicine,1997

4. Cyclic administration of pamidronate in children with severe osteogenesis imperfecta.;Glorieux;N Engl J Med,1998

5. Pamidronate treatment of severe osteogenesis imperfecta in children under 3 years of age.;Plotkin;J Clin Endocrinol Metab,2000

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical spectrum of rare bone fragility disorders and response to bisphosphonate treatment: a retrospective study;European Journal of Human Genetics;2024-06-26

2. Serum and Urinary Osteocalcin in Healthy 7- to 19-Year-Old Finnish Children and Adolescents;Frontiers in Pediatrics;2021-08-24

3. Bone density, fractures and the associated factors in iranian children and adolescent with Osteogenesis Imperfecta;BMC Pediatrics;2021-01-14

4. Retrospective Evaluation of Patients Diagnosed with Osteogenesis Imperfecta;Güncel Pediatri;2016-01-01

5. Beneficial effects of intravenous pamidronate treatment in children with osteogenesis imperfecta under 24 months of age;Journal of Bone and Mineral Metabolism;2014-10-16